Carotid Artery Disease News and Research

RSS
Approximately one-fourth of all strokes are caused by carotid artery disease, a condition wherein one or both carotid arteries in the neck become blocked by plaque, which can break off and cause stroke. Traditional surgical treatment for carotid artery disease often involves general anesthesia and requires an incision in a patient's neck to remove plaque from inside the artery wall. Carotid artery stenting is a minimally invasive treatment option for patients who require intervention to prevent a stroke and are at high risk for complications from traditional surgery. The procedure is performed by delivering a stent on a catheter through the femoral artery in the groin. The catheter is maneuvered through the patient's vasculature to the carotid artery. The stent, which is designed to prevent arterial plaque and debris from breaking off and blocking blood flow to the brain, is then expanded at the site of the blockage.
NYU Langone Medical Center researchers find that air pollution may pose significant stroke risk

NYU Langone Medical Center researchers find that air pollution may pose significant stroke risk

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Inflating balloon inside artery after stent placement increases patients' risk of serious complications

Inflating balloon inside artery after stent placement increases patients' risk of serious complications

High-dose statins could have added benefit of reducing gum inflammation

High-dose statins could have added benefit of reducing gum inflammation

Snoring may indicate future health risks

Snoring may indicate future health risks

Tirofiban effectively prevents strokes in high risk patients

Tirofiban effectively prevents strokes in high risk patients

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

Positive results from Alnylam’s ALN-PCS Phase I trial on severe hypercholesterolemia

Positive results from Alnylam’s ALN-PCS Phase I trial on severe hypercholesterolemia

Emboshield Pro safer in patients ineligible for standard surgical treatment of CAD

Emboshield Pro safer in patients ineligible for standard surgical treatment of CAD

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

NYU Langone cardiovascular experts present new research findings at AHA 2011

NYU Langone cardiovascular experts present new research findings at AHA 2011

Carotid artery stenting could treat severe disease lesions

Carotid artery stenting could treat severe disease lesions

New ESC Guidelines on diagnosis and treatment of peripheral artery disease

New ESC Guidelines on diagnosis and treatment of peripheral artery disease

Series of articles explore recent evidence-based vascular medicine

Series of articles explore recent evidence-based vascular medicine

Enrollment complete in Boston Scientific's Adapt Monorail Carotid Stent System trial

Enrollment complete in Boston Scientific's Adapt Monorail Carotid Stent System trial

FDA approves Abbott's RX ACCULINK Carotid Stent System

FDA approves Abbott's RX ACCULINK Carotid Stent System

FDA clears Reverse Medical's ReFlex Catheter for neurovascular procedure

FDA clears Reverse Medical's ReFlex Catheter for neurovascular procedure

Reverse Medical's ReFlex A+ Catheter receives European CE mark approval

Reverse Medical's ReFlex A+ Catheter receives European CE mark approval

CAS is an economically attractive alternative to endarterectomy for stroke patients

CAS is an economically attractive alternative to endarterectomy for stroke patients

Endologix announces initial PEVAR Trial presentation at 2011 iCON annual meeting

Endologix announces initial PEVAR Trial presentation at 2011 iCON annual meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.